PECAM1 and neuroblastoma: Using this approach, we have identified CD31+ cells carrying MYCN amplification in one-third of MYCN-amplified primary NB tested and in tumors formed by MYCN-amplified human NB cell lines in immunodeficient mice (Figures 1A,B).